A 91% increase in Total Revenue to $23.9M.
A Net Profit of $5.4M (PreTax) compared to Previous years loss of $2M.
An 80.2% increase in dose sales.
A 59% Increase in Cash Reserves to $10.8M
Increase in unit sales of Sir-Spheres from 737 doses in 2005 to 1320 in 2006